A MoB MBene-enhanced molecularly imprinted electrochemical platform for selective cabozantinib detection: from molecular design to green metrics computing

AGREEMIP: the analytical greenness assessment tool for molecularly imprinted polymers synthesis

10.1021/acssuschemeng.4c03874 · doi-reference

AGREE—analytical greenness metric approach and software

10.1021/acs.analchem.0c01887 · doi-reference

Limit of blank (LOB), limit of detection (LOD), and limit of quantification (LOQ)

10.19080/omcij.2018.07.555722 · doi-reference

Facile hydrothermal synthesis of MoB MBene nanosheets for high-performance wide-temperature lithium-ion batteries

10.1016/j.apsusc.2025.165387 · doi-reference

2D MoB MBene: an efficient co-catalyst for photocatalytic hydrogen production under visible light

10.1021/acsnano.4c02642 · doi-reference

Hydrothermal fabrication and electrochemical properties of MoB MBene as supercapacitor electrode material

10.1016/j.diamond.2025.113139 · doi-reference

MBene as novel and effective electrochemical material used to enhance paper-based biosensor for point-of-care testing ctDNA from mice serum

10.1016/j.cej.2024.155345 · doi-reference

Novel Cu nanocluster superlattice/MBene-induced ECL enhancement strategy for miRNA-221 detection

10.1016/j.cej.2023.147512 · doi-reference

Open-layered MBenes: comparisons of different wet etching techniques and electrochemical detection of heavy metal ions with high sensitivity & selectivity

10.1016/j.snb.2025.137258 · doi-reference

Advancing energy development with MBene: chemical mechanism, AI, and applications in energy storage and harvesting

10.1007/s40820-025-01941-8 · doi-reference

Two-dimensional (2D) transition metal carbides/nitrides (MXenes) and transition metal borides (MBenes) as emerging functional materials for electrochemical detection of food contaminants

10.1016/j.foodchem.2026.148620 · doi-reference

Unlocking the potential of MBenes for sensing applications: a review of gas and biosensor innovations

10.1016/j.ccr.2025.216458 · doi-reference

New two-dimensional transition metal borides for Li ion batteries and electrocatalysis

10.1039/c7ta08665b · doi-reference

Design of a molecularly imprinted polymer sensor modified with saffron-based copper nanoflowers for highly selective and sensitive determination of bortezomib

10.1016/j.talanta.2024.127005 · doi-reference

Fabrication of a molecularly imprinted polymer-based electrochemical sensor for the selective assay of antipsychotic drug clozapine and performance comparison with LC-MS/MS

10.1016/j.talanta.2024.126810 · doi-reference

Synthesis of molecularly imprinted polymers by photo-iniferter polymerization under visible light

10.1039/c7py01113j · doi-reference

Advances in the selection of functional monomers for molecularly imprinted polymers: a review

10.1002/jssc.202400353 · doi-reference

MIP sensors – the electrochemical approach

10.1007/s00216-011-5405-5 · doi-reference

Electrochemical sensor based on a carbon nanotube-modified imprinted sol–gel for selective and sensitive determination of β2-agonists

10.1007/s00604-013-1020-9 · doi-reference

Molecular imprinting in sol-gel materials: recent developments and applications

10.1007/s00604-004-0274-7 · doi-reference

Development of ultra-sensitive and selective molecularly imprinted polymer-based electrochemical sensor for L-lactate detection

10.1016/j.microc.2024.111163 · doi-reference

TiO2-embedded molecularly imprinted polymer as electrochemical sensor for ultrasensitive determination of glycopyrronium bromide: original scientific paper

10.5599/admet.3102 · doi-reference

A novel MXene-integrated MIP-based electrochemical sensor for highly selective and sensitive lenalidomide recognition

10.1016/j.talanta.2026.129809 · doi-reference

Developing a molecularly imprinted electrochemical sensor for selective detection of roxithromycin from food samples via green synthesis

10.1007/s12161-025-02967-9 · doi-reference

A high throughput method for monitoring of sorafenib, regorafenib, cabozantinib and their metabolites with UPLC-MS/MS in rat plasma

10.3389/fphar.2022.955263 · doi-reference

Development and validation of rp-HPLC method of cabozantinib in active pharmaceutical ingredient and pharmaceutical dosage form

10.9734/jpri/2021/v33i1131247 · doi-reference

Solid phase extraction prior to non-aqueous capillary electrophoresis with ultraviolet detection as a valuable strategy for therapeutic drug monitoring of cabozantinib

10.1016/j.microc.2022.107830 · doi-reference

A new method to determine the new C-Met inhibitor “cabozantinib” in dosage form and human plasma via micelle-enhanced spectrofluorimetry

10.1039/c5ra04109k · doi-reference

Concurrent detection of cabozantinib as an anticancer agent and its major metabolites in human serum using fluorescence-coupled micellar liquid chromatography

10.1016/j.arabjc.2021.103206 · doi-reference

Plasma cabozantinib level measurement in patients with renal cell and hepatocellular carcinomas using a simple HPLC–UV method suitable for clinical application

10.3390/curroncol30050367 · doi-reference

Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib

10.1001/jamadermatol.2014.2734 · doi-reference

FDA approval summary: cabozantinib for differentiated thyroid cancer

10.1158/1078-0432.ccr-22-0873 · doi-reference

Real-world efficacy and safety of cabozantinib and vandetanib in advanced medullary thyroid cancer

10.1089/thy.2020.0206 · doi-reference

Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 cabinet trial (alliance A021602)

10.1530/erc-25-0415 · doi-reference

Cabozantinib for HCC treatment, from clinical back to experimental models

10.3389/fonc.2021.756672 · doi-reference

Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 CABOSUN trial

10.1200/jco.2016.70.7398 · doi-reference

Quantitation of cabozantinib in human plasma by LC–MS/MS

10.1093/chromsci/bmab090 · doi-reference

Cabozantinib in the treatment of neuroendocrine neoplasms: insights across different tumor origins

10.1159/000543953 · doi-reference

Cabozantinib in thyroid cancer

10.2174/1574892810666150708110816 · doi-reference

Mechanism of action, synthesis, properties and analytical methods of cabozantinib

10.22159/ijap.2023v15i1.46409 · doi-reference